Attovia Therapeutics Prices IPO at $17 a Share, Seeks Up to $289 Million on Nasdaq
Attovia Therapeutics has priced an upsized IPO of 17,000,000 common shares at $17.00 each, with expected gross proceeds of $289.0 million before underwriting costs. The company will list on the Nasdaq Global Market under the symbol ATTO, with trading to start August 5, 2026 and closing aimed for August 6, 2026, subject to standard closing condition…